The company received a 1,000 million yen donation from its CEO and representative director, Ryotatsu Naoshiro, to strengthen its financial base. This follows significant losses (925 million yen net loss in FY2025 and 2,055 million yen quarterly loss in Q3 FY2026) resulting from compliance corrections in the home nursing care business and subsequent operational restructuring. The donation will be recorded as extraordinary income in the FY2026 financial statements.
¥1.0bn
›
Summary
The company received a 1,000 million yen donation from its CEO and representative director, Ryotatsu Naoshiro, to strengthen its financial base. This follows significant losses (925 million yen net loss in FY2025 and 2,055 million yen quarterly loss in Q3 FY2026) resulting from compliance corrections in the home nursing care business and subsequent operational restructuring. The donation will be recorded as extraordinary income in the FY2026 financial statements.
Counterparty: 苗代亮達 (Ryotatsu Naoshiro, Representative Director and President)